TPBG and colorectal carcinoma: We have previously demonstrated that CRC patients have higher numbers of Treg with a suppressive phenotype relative to healthy individuals [7, 15, 23] and that anti-5T4 responses are more likely to be controlled by these cells in CRC patients.